Change - Announcement of Appointment::Appointment of Non-Executive Non-Independent Chairman

Issuer & Securities

Issuer/ Manager
HEALTHWAY MEDICAL CORPORATION LIMITED
Securities
HEALTHWAY MEDICAL CORP LTD - SG1X09940682 - 5NG
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
02-Aug-2017 19:20:08
Status
New
Announcement Sub Title
Appointment of Non-Executive Non-Independent Chairman
Announcement Reference
SG170802OTHREF8Q
Submitted By (Co./ Ind. Name)
Anand Kumar
Designation
Director
Description (Please provide a detailed description of the event in the box below)
Appointment of Non-Executive Non-Independent Chairman

This announcement has been prepared by Healthway Medical Corporation Limited (the "Company") and its contents have been reviewed by PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"), for compliance with the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist. The Sponsor has not verified the contents of this announcement. This announcement has not been examined or approved by the SGX-ST. The Sponsor and the SGX-ST assume no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Gillian Goh, Director, Head of Continuing Sponsorship, (Mailing Address: 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and E-mail: sponsorship@ppcf.com.sg).

Additional Details

Date Of Appointment
02/08/2017
Name Of Person
Lee Luen-Wai, John
Age
68
Country Of Principal Residence
Hong Kong
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
Upon the recommendation of the Nominating Committee, which had reviewed the qualifications and experiences of Mr John Lee, the Board of Directors approved his appointment as Non-Executive Non-Independent Chairman of the Company.
Whether appointment is executive, and if so, the area of responsibility
Non-Executive
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Non-Executive Non-Independent Chairman
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Conflict of interests (including any competing business)
No
Working experience and occupation(s) during the past 10 years
1991 to Present
Lippo Limited, Managing Director

2005 to Present
Lippo Limited, CEO

1992 to Present
Lippo China Resources Limited, Executive Director

2011 to Present
Lippo China Resources Limited, CEO

1992 to Present
Hongkong Chinese Limited, Executive Director

2011 to Present
Hongkong Chinese Limited, CEO
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
Other Directorships
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Please see Appendix A
Present
Please see Appendix B
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
Yes
If Yes, Please provide full details
From May 2006 to December 2011, Mr John Lee was a Non-Executive Director of Export & Industry Bank, Inc. ("EIB"), a former listed company in the Republic of Philippines. Mr Lee was a nominated director of a shareholder of EIB. He resigned the directorship of EIB on 13th December, 2011. EIB was placed in receivership on 26th April, 2012.
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Disclosure applicable to the appointment of Director only.
Any prior experience as a director of a listed company?
Yes
If Yes, Please provide details of prior experience
(1) Lippo Limited (listed on the Mainboard of The Stock Exchange of Hong Kong) (March 21, 1991 - Present)

(2) Lippo China Resources Limited (listed on the Mainboard of The Stock Exchange of Hong Kong) (July 30, 1992 - Present)

(3) Hongkong Chinese Limited (listed on the Mainboard of The Stock Exchange of Hong Kong) (September 1, 1992 - Present)

(4) New World Development Company Limited (listed on the Mainboard of The Stock Exchange of Hong Kong) (August 2004 - Present)

(5) UMP Healthcare Holdings Limited (listed on the Mainboard of The Stock Exchange of Hong Kong) (November 2015 - Present)

(6) New World China Land Limited ("NWCL") (previously listed on the Mainboard of The Stock Exchange of Hong Kong) (December 2004 to September 2016). Due to the completion of the privatization, NWCL was delisted on 4 August 2016.

Attachments

Appendix A.pdf
Appendix B.pdf
Total size =175K